Literature DB >> 8434571

Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years.

M Morofuji-Hirata1, W Kajiyama, K Nakashima, A Noguchi, J Hayashi, S Kashiwagi.   

Abstract

To clarify events related to age dependence of human T-cell lymphotropic virus type I (HTLV-I) seroprevalence, the authors carried out two seroepidemiologic studies at a 9-year interval on residents of Yonaguni Island, Okinawa, Japan. The overall prevalence was 17.8% (345/1,943) in 1980 and 17.1% (264/1,543) in 1989-1990. The authors studied the relation of the HTLV-I infection rate to the birth year of 967 individuals tested in both years. Of the 967 individuals, 209 were positive for anti-HTLV-I in the 1980 survey. By the 1989-1990 survey, only 7 of the 758 anti-HTLV-I negative cases (0.9%) had become positive for anti-HTLV-I, and all 7 were over 40 years of age. For persons born in the same period, there was almost no difference between the prevalence of HTLV-I found in the 1980 survey and that found in the 1989-1990 survey. These data show that there were few new cases of HTLV-I infection and none in the lower age groups over the 9 years, which suggests that higher rates of HTLV-I infection in adults reflect past higher rates of infection as infants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434571     DOI: 10.1093/oxfordjournals.aje.a116600

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.

Authors:  J J Zarranz Imirizaldu; J C Gomez Esteban; I Rouco Axpe; T Perez Concha; F Velasco Juanes; I Allue Susaeta; J M Corral Carranceja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

2.  EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?

Authors:  Sandra Gofinet Pasoto; Renato Romera Natalino; Henrique Pires Chakkour; Vilma Dos Santos Trindade Viana; Cleonice Bueno; Elaine Pires Leon; Margarete Borges Gualhardo Vendramini; Mauricio Levy Neto; Eloisa Bonfa
Journal:  Rheumatol Int       Date:  2012-09-06       Impact factor: 2.631

3.  Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan.

Authors:  J Hayashi; E Yoshimura; A Nabeshima; Y Kishihara; H Ikematsu; M Hirata; Y Maeda; S Kashiwagi
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

4.  Predicting and Designing Epitope Ensemble Vaccines against HTLV-1.

Authors:  Saruar Alam; Md Kamrul Hasan; Omar Hamza Bin Manjur; Akib Mahmud Khan; Zinat Sharmin; Mahmud Arif Pavel; Md Faruk Hossain
Journal:  J Integr Bioinform       Date:  2020-01-08

5.  High prevalence of human T-lymphotropic virus infection in indigenous women from the peruvian Amazon.

Authors:  Magaly M Blas; Isaac E Alva; Patricia J García; Cesar Cárcamo; Silvia M Montano; Nicanor Mori; Ricardo Muñante; Joseph R Zunt
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

6.  The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Houshang Rafatpanah; Reza Farid Hosseini; Seyed Hassan Pourseyed
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.